Michael Gelband’s Tectonic Therapeutic TECX Stock Holding History

Michael Gelband’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.21M	Sell	35,239 -48,440	-58%	-$1.42M	0.01%	1009
2026 Q1	$2.59M	Sell	83,679 -27,509	-25%	-$677K	0.02%	669
2025 Q4	$2.32M	Buy	111,188 +98,171	+754%	+$1.82M	0.02%	720
2025 Q3	$204K	Buy	+13,017	New	+$269K	﹤0.01%	1384
2022 Q2	–	Sell	-877	Closed	-$14K	–	2543
2022 Q1	$14K	Sell	877 -230	-21%	-$4.75K	﹤0.01%	2113
2021 Q4	$51K	Sell	1,107 -967	-47%	-$55.6K	﹤0.01%	2030
2021 Q3	$139K	Buy	2,074 +381	+23%	+$31.3K	﹤0.01%	1854
2021 Q2	$181K	Buy	+1,693	New	+$201K	﹤0.01%	2020

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Michael Gelband's TECX Position: Q2 2026 in Review

Michael Gelband reduced its Tectonic Therapeutic (TECX) stake by 58% in Q2 2026, selling an estimated $1.42M and leaving 35,239 shares worth $1.21M. The position accounts for 0.01% of the portfolio, ranked #1009.

Michael Gelband first reported a position in TECX in Q2 2021 and has held it in 8 quarters since. The position peaked at $2.59M in Q1 2026. 122 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

Michael Gelband held 35,239 shares of Tectonic Therapeutic worth $1.21M as of Q2 2026.
Michael Gelband sold 48,440 Tectonic Therapeutic shares in Q2 2026, an estimated $1.42M.
Tectonic Therapeutic made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #1009 holding.
Michael Gelband first reported a position in Tectonic Therapeutic in Q2 2021 and has held it in 8 quarters since.
Michael Gelband's Tectonic Therapeutic position peaked at $2.59M in Q1 2026.
122 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.